Amneal Pharmaceuticals (NASDAQ:AMRX) used a presentation and Q&A session at the JPMorgan conference to outline its ongoing shift toward higher-value “affordable medicines” and specialty products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback